ArchiMed acquires neurodiagnostic devices provider Natus Medical
Natus shareholders received $33.50 in cash for each share of company common stock.
Central Nervous System
Latest in
Central Nervous System
The future of ALS devices: next gen assistive technology aims to give patients a voice
Brain-computer interfaces, IoT and AI to fuel the advancement of assistive technology devices for ALS patients.
By
Labcorp introduces blood test to detect neurodegenerative disease
The test will help diagnose diseases, such as multiple sclerosis, Alzheimer’s and Parkinson’s, as well as brain injuries.
The metaverse: the next frontier in clinical trials?
Digital simulation could help break down healthcare barriers, but experts caution the clinical trials sector to go slow.
By